Your browser doesn't support javascript.
loading
MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia.
Uddin, Muhammad Erfan; Eisenmann, Eric D; Li, Yang; Huang, Kevin M; Garrison, Dominique A; Talebi, Zahra; Gibson, Alice A; Jin, Yan; Nepal, Mahesh; Bonilla, Ingrid M; Fu, Qiang; Sun, Xinxin; Millar, Alec; Tarasov, Mikhail; Jay, Christopher E; Cui, Xiaoming; Einolf, Heidi J; Pelis, Ryan M; Smith, Sakima A; Radwanski, Przemyslaw B; Sweet, Douglas H; König, Jörg; Fromm, Martin F; Carnes, Cynthia A; Hu, Shuiying; Sparreboom, Alex.
Afiliação
  • Uddin ME; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Eisenmann ED; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Li Y; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Huang KM; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Garrison DA; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Talebi Z; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Gibson AA; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Jin Y; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Nepal M; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Bonilla IM; Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Fu Q; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Sun X; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Millar A; Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • Tarasov M; Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • Jay CE; Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Cui X; Novartis Institute for Biomedical Research, East Hanover, NJ 07936, USA.
  • Einolf HJ; Novartis Institute for Biomedical Research, East Hanover, NJ 07936, USA.
  • Pelis RM; Novartis Institute for Biomedical Research, East Hanover, NJ 07936, USA.
  • Smith SA; OSU Wexner Medical Center, Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Radwanski PB; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
  • Sweet DH; Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • König J; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
  • Fromm MF; Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Carnes CA; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
  • Hu S; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
  • Sparreboom A; Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Int J Mol Sci ; 23(15)2022 Aug 03.
Article em En | MEDLINE | ID: mdl-35955741
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Antiarrítmicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Antiarrítmicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos